With the analysis among 2,601 patents, we discovered top 316 key players by total patent application. KalVista Pharmaceuticals Ltd., Bristol Myers Squibb Co., BioCryst Pharmaceuticals, Inc. are dominant in this area. They take 18.38% of the total patent filing.
KalVista Pharmaceuticals Ltd.
United Kingdom
Patent: 189
New York, United States
Patent: 181
BioCryst Pharmaceuticals, Inc.
Alabama, United States
Patent: 108
Massachusetts, United States
Patent: 97
Nordrhein-Westfalen, Germany
Patent: 89
Takeda Pharmaceutical Co., Ltd.
Osaka-fu, Japan
Patent: 67
California, United States
Patent: 48
eXIthera Pharmaceuticals, Inc.
Massachusetts, United States
Patent: 48
Basel-Stadt, Switzerland
Patent: 47
Boehringer Ingelheim International GmbH
Rheinland-Pfalz, Germany
Patent: 41
With the analysis among 34 patents, we discovered top 5 start-ups by total patent application. Sixera Pharma AB, Attune Pharmaceuticals, Inc., Institut National de la Santé et de la Recherche Médicale are active in this area.
Attune Pharmaceuticals, Inc.
New York, United States
Patent: 11
Institut National de la Santé et de la Recherche Médicale
Hubei Sheng, China
Patent: 3
Herefordshire, United Kingdom
Patent: 1
With the analysis among related 722 patents applied in the last 5 years. We discover 117 most active companies in this area. The fast-growing KalVista Pharmaceuticals Ltd., BioCryst Pharmaceuticals, Inc., Boehringer Ingelheim International GmbH take 27.42% of patent filing during this period.
KalVista Pharmaceuticals Ltd.
United Kingdom
Patent: 102
BioCryst Pharmaceuticals, Inc.
Alabama, United States
Patent: 60
Boehringer Ingelheim International GmbH
Rheinland-Pfalz, Germany
Patent: 36
eXIthera Pharmaceuticals, Inc.
Massachusetts, United States
Patent: 34
Takeda Pharmaceutical Co., Ltd.
Osaka-fu, Japan
Patent: 30
New York, United States
Patent: 27
Colorado, United States
Patent: 19
Herefordshire, United Kingdom
Patent: 18
ActiveSite Pharmaceuticals, Inc.
California, United States
Patent: 18
With the analysis among related 722 patents in last 5 years, we discover 72 new entrants. Rezolute, Inc., NeRRe Therapeutics Ltd., Shire Human Genetic Therapies, Inc. are the most active new entrants in this area.
Colorado, United States
Patent: 19
Herefordshire, United Kingdom
Patent: 18
Shire Human Genetic Therapies, Inc.
Massachusetts, United States
Patent: 16
TRON - Translationale Onkologie an der Universitätsmedizin der
Rheinland-Pfalz, Germany
Patent: 14
Jiangsu Hengrui Pharmaceuticals Co., Ltd.
Jiangsu Sheng, China
Patent: 13
Shanghai Suncadia Pharmaceuticals Co., Ltd.
Shanghai Senhui Pharmaceutical Co., Ltd.
Shanghai Shi, China
Patent: 12
Rheinland-Pfalz, Germany
Patent: 11
Intellia Therapeutics, Inc.
Massachusetts, United States
Patent: 10
Nordrhein-Westfalen, Germany
Patent: 9
With the analysis among 188 patents, we discovered top 63 universities and scientific research institutions by total patent application. Hengyang Normal University, Emory University, China Agricultural University are dominant in this area. They take 19.68% of the total patent filing.
Hengyang Normal University
Hunan Sheng, China
Patent: 5
Georgia, United States
Patent: 4
China Agricultural University
Beijing Shi, China
Patent: 4
Fukuoka-ken, Japan
Patent: 4
Université François-Rabelais de Tours
The University of Reading
READING, United Kingdom
Patent: 3
Medical University of South Carolina
South Carolina, United States
Patent: 3